InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Sumner Michael John. Director active across 2 companies, notably INOVIO PHARMACEUTICALS, INC.. In total, 10 filings have been recorded. Activity tracked since 15 May 2025. The latest transaction was filed on 31 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Sumner Michael John is a declarant linked to INOVIO PHARMACEUTICALS, INC., where his listed role is Chief Medical Officer. The file shows 4 filings in total, and the sampled recent filings cover the period from 2023-07-03 to 2025-02-28, with the modal transaction nature listed as option exercise.